OGN – organon & co. (US:NASDAQ)

News

Organon & Co. (NYSE:OGN) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Organon & Co. (NYSE:OGN) was downgraded by analysts at Wall Street Zen
Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026
Organon Completes Divestiture of JADA® System to Laborie
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com